IQVIA Price Target Lowered to 250.00 at The Goldman Sachs Group
| IQV Stock | USD 144.95 1.41 0.98% |
Slightly above 52% of IQVIA Holdings' investor base is interested to short. The analysis of overall sentiment of trading IQVIA Holdings stock suggests that many investors are impartial at this time. IQVIA Holdings' investing sentiment can be driven by a variety of factors including economic data, IQVIA Holdings' earnings reports, geopolitical events, and overall market trends.
IQVIA had its price objective decreased by The Goldman Sachs Group from 280.00 to 250.00 in a research report released on Friday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the medical research companys stock. A number of other equities analysts have also weighed in on
Read at thelincolnianonline.com
 |
IQVIA Holdings Fundamental Analysis
We analyze IQVIA Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IQVIA Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IQVIA Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
IQVIA Holdings is currently under evaluation in target price category among its peers.
IQVIA Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IQVIA Holdings stock to make a market-neutral strategy. Peer analysis of IQVIA Holdings could also be used in its relative valuation, which is a method of valuing IQVIA Holdings by comparing valuation metrics with similar companies.
Peers
IQVIA Holdings Related Equities
| TWST | Twist Bioscience | 1.71 | ||||
| RVTY | Revvity | 1.12 | ||||
| ICLR | ICON PLC | 1.02 | ||||
| LH | Laboratory | 0.40 | ||||
| CRL | Charles River | 0.29 | ||||
| MEDP | Medpace Holdings | 0.21 | ||||
| MTD | Mettler Toledo | 0.14 | ||||
| QGEN | Qiagen NV | 0.23 | ||||
| WAT | Waters | 0.26 | ||||
| IDXX | IDEXX Laboratories | 0.87 | ||||
| NEOG | Neogen | 3.13 |
Additional Tools for IQVIA Stock Analysis
When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.